HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 14 analysts with an average price target of $11.35. This is a potential upside of $4.26 (60.08%) from yesterday's end of day stock price of $7.09.

Health Catalyst's activity chart (see below) currently has 129 price targets and 132 ratings on display. The stock rating distribution of HCAT is 32.61% HOLD and 67.39% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.95% with an average time for these price targets to be met of 102.88 days.

Highest price target for HCAT is $14, Lowest price target is $9, average price target is $11.35.

Most recent stock forecast was given by JESSICA TASSAN from PIPER SANDLER on 26-Nov-2024. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 15 are a HOLD (32.61%), 31 are a BUY (67.39%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$4.91 (69.25%)

$11

1 months ago
(26-Nov-2024)

2/12 (16.67%)

$3.26 (37.30%)

1

Buy

$10.5

$3.41 (48.10%)

$12

1 months 13 days ago
(13-Nov-2024)

3/9 (33.33%)

$1.69 (19.18%)

269

Hold

$9

$1.91 (26.94%)

$8

1 months 19 days ago
(07-Nov-2024)

8/13 (61.54%)

$0.43 (5.02%)

42

Buy

$10

$2.91 (41.04%)

$8

2 months 18 days ago
(08-Oct-2024)

4/8 (50%)

$2.17 (27.71%)

69

Buy

$11

$3.91 (55.15%)

$11

7 months 5 days ago
(21-May-2024)

4/11 (36.36%)

$4.23 (62.48%)

96

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 102.88 days on average for the stock forecasts to be realized with a an average price target met ratio 37.95

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 9 price targets and 6 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

John Ransom with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?